Project Details
Description
An Open-Label Extension Study to Assess the Long- Term Safety and Tolerability of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Fragile X Syndrome
| Status | Active |
|---|---|
| Effective start/end date | 5/18/22 → 7/30/27 |
Funding
- ZYNERBA PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.